Vcanbio Cell & Gene Engineering Corp., Ltd (SHA:600645)
26.43
+0.28 (1.07%)
Apr 29, 2026, 1:05 PM CST
22.70% (1Y)
| Market Cap | 11.92B |
| Revenue (ttm) | 1.42B |
| Net Income (ttm) | 110.05M |
| Shares Out | 455.90M |
| EPS (ttm) | 0.24 |
| PE Ratio | 109.25 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 3,266,900 |
| Average Volume | 14,205,403 |
| Open | 26.16 |
| Previous Close | 26.15 |
| Day's Range | 25.91 - 26.44 |
| 52-Week Range | 20.98 - 32.99 |
| Beta | 0.27 |
| RSI | 35.05 |
| Earnings Date | Apr 25, 2026 |